15-73329573-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_005477.3(HCN4):c.1590G>C(p.Lys530Asn) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000000684 in 1,461,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005477.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HCN4 | NM_005477.3 | c.1590G>C | p.Lys530Asn | missense_variant, splice_region_variant | 4/8 | ENST00000261917.4 | |
HCN4 | XM_011521148.3 | c.372G>C | p.Lys124Asn | missense_variant, splice_region_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HCN4 | ENST00000261917.4 | c.1590G>C | p.Lys530Asn | missense_variant, splice_region_variant | 4/8 | 1 | NM_005477.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461634Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727150
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies suggest a damaging effect on channel function (Duhme et al., 2013); This variant is associated with the following publications: (PMID: 24569893, 23178648) - |
Brugada syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | May 30, 2021 | This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been reported to affect HCN4 protein function (PMID: 23178648). This variant has been observed in individual(s) with tachycardia–bradycardia syndrome and persistent atrial fibrillation (PMID: 23178648). ClinVar contains an entry for this variant (Variation ID: 519553). This sequence change replaces lysine with asparagine at codon 530 of the HCN4 protein (p.Lys530Asn). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and asparagine. This variant also falls at the last nucleotide of exon 4 of the HCN4 coding sequence, which is part of the consensus splice site for this exon. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2017 | The c.1590G>C variant (also known as p.K530N), located in coding exon 4 of the HCN4 gene, results from a G to C substitution at nucleotide position 1590. This results in an amino acid substitution of lysine with asparagine at codon 530, an amino acid with similar properties. This nucleotide change occurs in the last base pair of coding exon 4, which makes it likely to have some effect on normal mRNA splicing. Using the BDGP and ESEfinder splice site prediction tools, this nucleotide alteration is predicted to weaken the efficiency of the native splice donor site; however, direct evidence is unavailable. This alteration was reported to segregate with atrial fibrillation in one family in an age dependent manner. In addition, in vitro studies suggested that co-expression of mutant and wild-type channel in HEK-293 cells could affect channel gating (Duhme N et al. Eur. Heart J., 2013 Sep;34:2768-75). Both the nucleotide and amino acid positions are highly conserved in available vertebrate species. In addition, this amino acid alteration is predicted to be probably damaging and deleterious by PolyPhen and SIFT in silico analyses, respectively. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at